USX:AMRX - Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc. Cl
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts
• Options

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2016 Q4	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	10.55% 1.6%	10.51% -0.4%	10.74% 2.2%	10.91% 1.6%	10.86% -0.5%	10.82% -0.3%	10.82% 0.0%	10.89% 0.6%	10.87% -0.2%	11.05% 1.7%	53.53% 384.3%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.45% -	0.68% 50.7%	0.51% -24.9%	0.08% -83.4%	-6.29% -	-6.17% -	-5.88% -	-5.93% -	-0.09% -	0.43% -	-3.51% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	34.25% 6.9%	37.24% 8.7%	36.73% -1.4%	35.84% -2.4%	34.87% -2.7%	34.39% -1.4%	35.47% 3.1%	34.69% -2.2%	34.94% 0.7%	35.46% 1.5%	34.28% -3.3%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	7.3% 57.2%	9.82% 34.5%	9.26% -5.7%	7.97% -14.0%	6.9% -13.4%	6.25% -9.4%	8.54% 36.7%	8.96% 4.9%	9.86% 10.1%	10.95% 11.0%	9.37% -14.5%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.06B 3.5%	2.07B 0.5%	2.09B 1.3%	2.1B 0.2%	2.12B 1.2%	2.14B 0.8%	2.21B 3.4%	2.27B 2.7%	2.31B 1.7%	2.39B 3.2%	2.39B 0.3%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.02B 1.6%	3.97B -1.2%	3.94B -0.9%	3.89B -1.3%	4.04B 3.9%	3.87B -4.1%	3.8B -1.9%	3.63B -4.5%	3.7B 2.0%	3.69B -0.4%	3.47B -5.8%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.63B 1.1%	3.59B -1.1%	3.57B -0.5%	3.48B -2.6%	3.85B 10.6%	3.66B -5.0%	3.62B -1.1%	3.46B -4.2%	3.52B 1.5%	3.5B -0.6%	3.45B -1.2%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	346.11M 7.1%	350.51M 1.3%	360.34M 2.8%	391.12M 8.5%	280.33M -28.3%	297.47M 6.1%	298.42M 0.3%	294.41M -1.3%	318.17M 8.1%	330.86M 4.0%	19.78M -94.0%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	246.93M -48.4%	284.52M 15.2%	241.82M -15.0%	214.03M -11.5%	140.45M -34.4%	151.65M 8.0%	65.1M -57.1%	84.47M 29.8%	198.65M 135.2%	186.46M -6.1%	345.58M 85.3%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	268.27M -34.1%	283.65M 5.7%	347.12M 22.4%	455.81M 31.3%	283.15M -37.9%	310.62M 9.7%	256.74M -17.3%	216.54M -15.7%	98.18M -54.7%	95.89M -2.3%	35.23M -63.3%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	282.74M -37.8%	310.11M 9.7%	256.74M -17.2%	217.42M -15.3%	99.26M -54.3%	97.66M -1.6%	35.23M -63.9%	154.41M 338.3%	118.55M -23.2%	99.48M -16.1%	99.11M -0.4%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	175.96M -56.8%	219.34M 24.7%	189.18M -13.7%	161.41M -14.7%	79.76M -50.6%	53.27M -33.2%	-25.5M -	-5.18M -	113.83M -	137.5M 20.8%	276.39M 101.0%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.73M -	33.67M 89.9%	20.17M -40.1%	-835K -	-273.09M -	-269.39M -	-254.79M -	-258.42M -	11.34M -	38.76M 241.8%	-48.72M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	9.23M -	13.96M 51.4%	10.62M -23.9%	1.76M -83.4%	-133.58M -	-132.03M -	-129.99M -	-134.77M -	-2.05M -	10.32M -	-83.99M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.06 -	0.09 50%	0.07 -22.2%	0.01 -85.7%	-0.89 -	-0.87 -	-0.86 -	-0.9 -	-0.01 -	0.06 -	-0.48 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.83% -	-1.22% -	-1.79% -	0.49% -	-35.98% -	-0.93% -	-1.45% -	-2.34% -	3.89% -	2.98% -23.3%	-52.79% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.23% -	-0.11% -	-0.16% -	0.04% -	-3.05% -	-0.07% -	-0.11% -	-0.19% -	0.33% -	0.26% -19.4%	-2.31% -